Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Morepen Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500288NSE Symbol: MOREPENLABP/E(TTM):39.64
ISIN Demat:INE083A01026Div & Yield %:0.49EPS(TTM):1.03
Book Value(Rs):21.7626606Market Cap ( Cr.):2237.29Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 1554.541537.591338.881449.271112.42791.99
Excise Duty0.000.000.000.000.000.00
Net Sales1554.541537.591338.881449.271112.42791.99
Other Income 15.7212.575.7610.2411.779.42
Stock Adjustments 44.36-5.13-16.54-1.7441.987.58
Total Income1614.621545.031328.101457.771166.17808.99
EXPENDITURE :      
Raw Materials 1019.99945.15886.48988.81778.60528.67
Power & Fuel Cost40.6234.0923.7818.9313.0012.56
Employee Cost 177.22160.28146.19150.00123.2098.07
Other Manufacturing Expenses 52.1544.1933.8123.3913.5710.54
Selling and Administration Expenses 134.27163.47111.6287.9082.3673.37
Miscellaneous Expenses 21.2323.4743.1949.3631.3011.89
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1445.481370.641245.081318.391042.03735.10
Operating Profit169.13174.3983.03139.37124.1573.89
Interest 7.103.511.98-7.371.791.97
Gross Profit162.03170.8881.05146.74122.3671.92
Depreciation24.4421.9018.0121.1928.1134.43
Profit Before Tax137.59148.9863.04125.5594.2537.49
Tax31.2838.4816.6022.000.005.15
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax4.73-0.440.202.480.000.00
Reported Net Profit101.58110.9446.24101.0694.2532.33
Extraordinary Items 0.000.000.000.000.000.00
Adjusted Net Profit101.58110.9446.24101.0694.2532.33
Adjst. below Net Profit 0.000.000.000.000.000.00
P & L Balance brought forward328.20217.27171.0374.96-19.29-51.62
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.000.005.000.000.00
P & L Balance carried down429.78328.20217.27171.0374.96-19.29
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %10.000.000.000.000.000.00
Earnings Per Share-Unit Curr1.852.170.902.122.100.72
Earnings Per Share(Adj)-Unit Curr1.852.170.902.122.100.72
Book Value-Unit Curr21.5617.3915.2611.978.926.83